Literature DB >> 17097072

Striatal function in generalized social phobia: a functional magnetic resonance imaging study.

Jitender Sareen1, Darren W Campbell, William D Leslie, Krisztina L Malisza, Murray B Stein, Martin P Paulus, Laura B Kravetsky, Kevin D Kjernisted, John R Walker, Jeffrey P Reiss.   

Abstract

BACKGROUND: Although evidence suggests the involvement of the amygdala in generalized social phobia (GSP), few studies have examined other neural regions. Clinical, preclinical, and dopamine receptor imaging studies demonstrating altered dopaminergic functioning in GSP suggest an association with striatal dysfunction. This is the first functional magnetic resonance imaging (fMRI) study to use a cognitive task known to involve the striatum to examine the neural correlates of GSP. We examined whether subjects with GSP had differential activation in striatal regions compared with healthy control subjects while engaged in a cognitive task that has been shown to activate striatal regions reliably.
METHODS: Ten adult, unmedicated subjects with a primary DSM-IV diagnosis of GSP and 10 age-, gender-, and education-matched healthy comparison subjects underwent fMRI while performing the implicit sequence learning task.
RESULTS: The GSP and healthy comparison subjects did not differ significantly on the behavioral performance of the task. Subjects with GSP, however, had significantly reduced neural activation related to implicit learning compared with healthy comparison subjects in the left caudate head, left inferior parietal lobe, and bilateral insula.
CONCLUSIONS: These findings support the hypothesis that GSP is associated with striatal dysfunction and further the neurobiological understanding of this complex anxiety disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097072     DOI: 10.1016/j.biopsych.2006.05.043

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  24 in total

1.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

Review 2.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

3.  Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series.

Authors:  Ahmet Koyuncu; Fahri Çelebi; Erhan Ertekin; Burcu Ece Kök; Raşit Tükel
Journal:  Ther Adv Psychopharmacol       Date:  2017-06-21

4.  Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.

Authors:  Franklin R Schneier; Anissa Abi-Dargham; Diana Martinez; Mark Slifstein; Dah-Ren Hwang; Michael R Liebowitz; Marc Laruelle
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 5.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 6.  The role of neuroimaging for the diagnosis and treatment of anxiety disorders.

Authors:  Martin P Paulus
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

7.  When social anxiety disorder co-exists with risk-prone, approach behavior: investigating a neglected, meaningful subset of people in the National Comorbidity Survey-Replication.

Authors:  Todd B Kashdan; Patrick E McKnight; J Anthony Richey; Stefan G Hofmann
Journal:  Behav Res Ther       Date:  2009-03-28

8.  Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder.

Authors:  Kenneth D Gadow; Jasmin Roohi; Carla J DeVincent; Eli Hatchwell
Journal:  J Child Psychol Psychiatry       Date:  2008-12       Impact factor: 8.982

9.  Brain activation during anticipatory anxiety in social anxiety disorder.

Authors:  Stephanie Boehme; Viktoria Ritter; Susan Tefikow; Ulrich Stangier; Bernhard Strauss; Wolfgang H R Miltner; Thomas Straube
Journal:  Soc Cogn Affect Neurosci       Date:  2013-08-11       Impact factor: 3.436

10.  Functional MRI of verbal self-monitoring in schizophrenia: performance and illness-specific effects.

Authors:  Veena Kumari; Dominic Fannon; Dominic H Ffytche; Vinodkumar Raveendran; Elena Antonova; Preethi Premkumar; Michael A Cooke; Ananatha P P Anilkumar; Steven C R Williams; Christopher Andrew; Louise C Johns; Cynthia H Y Fu; Philip K McGuire; Elizabeth Kuipers
Journal:  Schizophr Bull       Date:  2008-11-07       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.